CN106636461A - Detection primer set and method capable of simultaneously detecting and distinguishing SIV, SRV and STLV - Google Patents
Detection primer set and method capable of simultaneously detecting and distinguishing SIV, SRV and STLV Download PDFInfo
- Publication number
- CN106636461A CN106636461A CN201610948583.XA CN201610948583A CN106636461A CN 106636461 A CN106636461 A CN 106636461A CN 201610948583 A CN201610948583 A CN 201610948583A CN 106636461 A CN106636461 A CN 106636461A
- Authority
- CN
- China
- Prior art keywords
- siv
- stlv
- srv
- detection
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 60
- 241001529934 Simian T-lymphotropic virus 3 Species 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000009396 hybridization Methods 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 6
- 239000002299 complementary DNA Substances 0.000 claims description 6
- 238000004925 denaturation Methods 0.000 claims description 4
- 230000036425 denaturation Effects 0.000 claims description 4
- 238000000137 annealing Methods 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 125000006850 spacer group Chemical group 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 239000011325 microbead Substances 0.000 claims 5
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 15
- 239000004005 microsphere Substances 0.000 abstract description 14
- 241000700605 Viruses Species 0.000 abstract description 11
- 239000012634 fragment Substances 0.000 abstract description 2
- 238000007403 mPCR Methods 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 241000713311 Simian immunodeficiency virus Species 0.000 description 17
- 239000000243 solution Substances 0.000 description 10
- 241000282693 Cercopithecidae Species 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 7
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 238000010171 animal model Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241001430294 unidentified retrovirus Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 101100219553 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SRV2 gene Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 101150071661 SLC25A20 gene Proteins 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 101150102633 cact gene Proteins 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 108700004025 env Genes Proteins 0.000 description 1
- 101150030339 env gene Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108700004026 gag Genes Proteins 0.000 description 1
- 101150098622 gag gene Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 230000037195 reproductive physiology Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种可同时检测并区分SIV、SRV、STLV的检测引物组及方法。检测引物组包括SIV、SRV、STLV三种不同病毒的特异序列引物,并带有特定的Tag序列。其检测方法是通过提取血液样本中的病毒总DNA,通过多重PCR同时扩增三种病毒的目标片段,然后将扩增产物与荧光编码微球及链霉亲和素‑藻红蛋白溶液杂交,通过检测仪器读取MFI值,以此判定是否含有这三种类型的病毒。本发明可同时对SIV、SRV、STLV三种不同类型的病毒进行检测并区分开来。本发明具有高特异性、高灵敏度、快速高效、成本低、结果准确易读等优点,非常适于在各级检测单位进行推广应用。The invention discloses a detection primer set and method capable of simultaneously detecting and distinguishing SIV, SRV and STLV. The detection primer set includes specific sequence primers of three different viruses, SIV, SRV, and STLV, and has a specific Tag sequence. The detection method is to extract the total virus DNA in the blood sample, and simultaneously amplify the target fragments of the three viruses through multiplex PCR, and then hybridize the amplified products with fluorescently encoded microspheres and streptavidin-phycoerythrin solution, Read the MFI value through the detection instrument to determine whether it contains these three types of viruses. The invention can simultaneously detect and distinguish three different types of viruses: SIV, SRV and STLV. The invention has the advantages of high specificity, high sensitivity, fast and high efficiency, low cost, accurate and easy-to-read results, and is very suitable for popularization and application in various detection units.
Description
技术领域technical field
本发明属于分子生物学技术领域,涉及实验动物相关病原的检测方法,具体涉及一种可同时检测并区分SIV、SRV、STLV的检测引物组及方法。The invention belongs to the technical field of molecular biology and relates to a detection method for pathogens related to experimental animals, in particular to a detection primer set and method capable of simultaneously detecting and distinguishing SIV, SRV and STLV.
背景技术Background technique
非人灵长类动物在进化上与人类密切相关,且具有自然分布广、数量多,易于饲养等特点被广泛应用于生殖生理、药物毒理、生物制品和人类疾病模型的研究。我国非人灵长类资源丰富,主要集中在我国广东、广西、云南、四川、海南等南方地区,目前饲养的企业有50余家,存栏规模30万只以上,每年用于科学研究的实验猴有3万余只,每年出口2万余只。随着实验用猴和饲养企业的增多,猴类自身携带的病原逐渐引起人们的关注,使得人类在与猴接触的过程中,感染病原的机会明显增加,特别是那些目前很难治愈的诸如AIDS等疾病的出现,更加增加了职业人员的风险。另外,实验猴携带病原也严重影响科学研究结果的准确性和真实性,损害了企业的经济效益。而目前在实验猴中三种最常携带的病毒为猴D型逆转录病毒(SRV)、猴免疫缺陷病毒(SIV)和猴T淋巴细胞趋向性病毒(STLV)。Non-human primates are closely related to humans in evolution, and have the characteristics of wide natural distribution, large numbers, and easy breeding. They are widely used in the research of reproductive physiology, drug toxicology, biological products and human disease models. my country is rich in non-human primate resources, which are mainly concentrated in southern regions such as Guangdong, Guangxi, Yunnan, Sichuan, and Hainan. There are currently more than 50 breeding companies with a population of more than 300,000 monkeys, which are used for scientific research every year. There are more than 30,000 pieces, and more than 20,000 pieces are exported every year. With the increase of experimental monkeys and breeding enterprises, the pathogens carried by monkeys have gradually attracted people's attention, which makes the chances of human beings infected with monkeys significantly increased during the process of contact with monkeys, especially those that are currently difficult to cure such as AIDS. The emergence of other diseases has increased the risk of occupational personnel. In addition, the pathogens carried by experimental monkeys also seriously affect the accuracy and authenticity of scientific research results and damage the economic benefits of enterprises. At present, the three most commonly carried viruses in experimental monkeys are simian D retrovirus (SRV), simian immunodeficiency virus (SIV) and simian T lymphotropic virus (STLV).
在现有的实验的动物质量检测标准中,对上述三个病原的检测方法仍然采用的ELISA或IFA的检测方法,该检测方法特异性差,灵敏度低,假阳性高,还必须结合WB检测特异性抗体才能最终确诊。ELISA法和IFA法检测的假阳性率高及WB法操作程序复杂,在一定程度上限制了其应用范围。因此,不论是为了保障整个饲养猴群的健康还是饲养人员、科研人员的人身安全,都有必要建立一种方便、快捷、灵敏、特异性强的检测方法。In the existing experimental animal quality testing standards, the detection methods for the above three pathogens still use ELISA or IFA detection methods, which have poor specificity, low sensitivity, and high false positives, and must also be combined with WB detection specificity Antibodies are the only way to make a definitive diagnosis. The high false positive rate of ELISA and IFA and the complicated operating procedures of WB method limit their application to a certain extent. Therefore, it is necessary to establish a convenient, fast, sensitive and specific detection method, whether it is to protect the health of the entire breeding monkey group or the personal safety of the breeding personnel and scientific researchers.
发明内容Contents of the invention
本发明的一个目的在于提供一种可同时检测并区分SIV、SRV、STLV的检测引物组。One object of the present invention is to provide a detection primer set that can simultaneously detect and distinguish SIV, SRV, and STLV.
本发明的另一个目的在于提供一种可同时检测并区分SIV、SRV、STLV的方法。Another object of the present invention is to provide a method for simultaneously detecting and distinguishing SIV, SRV, and STLV.
本发明所采取的技术方案是:The technical scheme that the present invention takes is:
一种可同时检测并区分SIV、SRV、STLV的检测引物组,包括三对引物,其核苷酸序列如下所示:A detection primer set capable of simultaneously detecting and distinguishing SIV, SRV, and STLV, including three pairs of primers, the nucleotide sequence of which is as follows:
SIV引物:SIV primers:
SIV-F:5’-ACGACCCGGCGGAAAGAAAAAGT-3’(SEQ ID NO:1);SIV-F: 5'-ACGACCCGGCGGAAAGAAAAAGT-3' (SEQ ID NO: 1);
SIV-B:5’-TGCACCAGATGACGCAGACAGT-3’(SEQ ID NO:2);SIV-B: 5'-TGCACCAGATGACGCAGACAGT-3' (SEQ ID NO: 2);
SRV引物:SRV primers:
SRV-F:5’-AYGGGGCTACTGCYCCATA-3’(SEQ ID NO:3);SRV-F: 5'-AYGGGGCTACTGCYCCATA-3' (SEQ ID NO: 3);
SRV-B:5’-GCCATTACCKGCYTGTTGATT-3’(SEQ ID NO:4);SRV-B: 5'-GCCATTACCKGCYTGTTGATT-3' (SEQ ID NO: 4);
STLV引物:STLV primers:
STLV-F:5’-GTGCCAATCATGGACCTGCC-3’(SEQ ID NO:5);STLV-F: 5'-GTGCCAATCATGGACCTGCC-3' (SEQ ID NO: 5);
STLV-B:5’-TCCTGGAGCGTCGATTAGAAGG-3’(SEQ ID NO:6)。STLV-B: 5'-TCCTGGAGCGTCGATTAGAAGG-3' (SEQ ID NO: 6).
优选的,引物SIV-F、SRV-F、STLV-F引物序列的5’端通过间隔臂序列添加有Tag序列。Preferably, the 5' ends of the primer sequences of primers SIV-F, SRV-F, and STLV-F are added with a Tag sequence through a spacer sequence.
优选的,引物SIV-F、SRV-F、STLV-F引物的Tag序列分别为:Preferably, the Tag sequences of primers SIV-F, SRV-F, and STLV-F primers are respectively:
SIV-F的Tag序列为:5’-ATCTCAATTACAATAACACACAAA-3’(SEQ ID NO:7);The Tag sequence of SIV-F is: 5'-ATCTCAATTACAATAACACACAAA-3' (SEQ ID NO: 7);
SRV-F的Tag序列为:5’-TACTTCTTTACTACAATTTACAAC-3’(SEQ ID NO:8);The Tag sequence of SRV-F is: 5'-TACTTCTTTTACTACAATTTACAAC-3' (SEQ ID NO: 8);
STLV-F的Tag序列为:5’-CTTAAACTCTACTTACTTCTAATT-3’(SEQ ID NO:9)。The Tag sequence of STLV-F is: 5'-CTTAAACTCTACTTACTTCTAATT-3' (SEQ ID NO: 9).
优选的,引物SIV-R、SRV-R、STLV-R引物序列的5’端添加有生物素标记。Preferably, the 5' end of the primer sequence of primer SIV-R, SRV-R, STLV-R is added with a biotin label.
一种可同时检测并区分SIV、SRV、STLV的方法,包括如下步骤:A method capable of simultaneously detecting and distinguishing SIV, SRV, and STLV, comprising the steps of:
1)提取待检样品RNA和合成cDNA;1) Extract RNA and synthesize cDNA from the sample to be tested;
2)PCR扩增反应;2) PCR amplification reaction;
3)PCR产物与荧光编码微球杂交。3) PCR products are hybridized with fluorescently encoded microspheres.
4)信号检测及结果判读。4) Signal detection and result interpretation.
优选的,PCR扩增反应程序为94℃预变性5min;94℃变性30s,58℃退火30s,72℃延伸30s,循环33次;72℃延伸5min。Preferably, the PCR amplification reaction program is pre-denaturation at 94°C for 5 minutes; denaturation at 94°C for 30 s, annealing at 58°C for 30 s, extension at 72°C for 30 s, and 33 cycles; extension at 72°C for 5 min.
优选的,PCR产物与荧光编码微球溶液的杂交体系为:荧光编码微球溶液20μl,链霉亲和素-藻红蛋白溶液75μl,PCR产物5μl。Preferably, the hybridization system between the PCR product and the fluorescently encoded microsphere solution is: 20 μl of the fluorescently encoded microsphere solution, 75 μl of the streptavidin-phycoerythrin solution, and 5 μl of the PCR product.
优选的,荧光编码微球分别标记有与上述所述Tag序列反向互补的序列。Preferably, the fluorescently encoded microspheres are respectively marked with a sequence reversely complementary to the aforementioned Tag sequence.
优选的,PCR产物与荧光编码微球杂交的程序为:45℃杂交35min。Preferably, the procedure for hybridizing the PCR product with the fluorescently encoded microspheres is: hybridize at 45° C. for 35 minutes.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明具有高特异性、高灵敏度、快速高效、成本低、结果准确易读等有益效果:The present invention has beneficial effects such as high specificity, high sensitivity, fast and efficient, low cost, accurate and easy-to-read results:
1)高特异性:本发明根据SIV、SRV、STLV三个病毒高度保守序列,分别设计了三套特异性引物,三套引物Tm值接近,可接受高退火温度进行PCR反应,保证了可以进行多重PCR反应和高特异性;1) High specificity: According to the highly conserved sequences of SIV, SRV and STLV, the present invention designs three sets of specific primers respectively. The Tm values of the three sets of primers are close, and high annealing temperature can be accepted for PCR reaction, which ensures that Multiple PCR reactions and high specificity;
2)高灵敏度:由于采取荧光信号读取方式判定检测结果,该检测方法比传统的PCR检测方法要高出1至2个数量级。2) High sensitivity: Since the detection result is judged by the fluorescent signal reading method, the detection method is 1 to 2 orders of magnitude higher than the traditional PCR detection method.
3)快速高效:只需提取一份样本即可同时对三个病毒进行检测并予以区分,大大缩短了检测时间和样本量;3) Fast and efficient: Only one sample can be extracted to detect and distinguish three viruses at the same time, which greatly shortens the detection time and sample size;
3)成本低:由于只需要一份试剂便可检测一份样本的多个指标,打破传统方法一份试剂检测一份样本的一个指标的局限,实现真正的高通量检测,大大降低了检测试剂的成本;3) Low cost: Since only one reagent is needed to detect multiple indicators of one sample, it breaks the limitation of the traditional method that one reagent can detect one indicator of one sample, realizes real high-throughput detection, and greatly reduces the detection cost. the cost of reagents;
4)结果准确易读:检测荧光信号通过Luminex 200仪器进行读取,不需要进行电泳,检测结果容易判定,准确度高,该检测方法符合现代化检测的需求。4) The result is accurate and easy to read: the detection fluorescence signal is read by Luminex 200 instrument without electrophoresis, the detection result is easy to judge, and the accuracy is high. This detection method meets the needs of modern detection.
附图说明Description of drawings
图1是实施例3特异性的检测结果图;Fig. 1 is the detection result figure of embodiment 3 specificity;
图2是实施例4各病毒质粒的灵敏度检测结果图。Fig. 2 is the sensitivity detection result figure of each virus plasmid of embodiment 4.
具体实施方式detailed description
以下结合实施例对本发明作进一步的说明,但并不局限于此。The present invention will be further described below in conjunction with embodiment, but is not limited thereto.
实施例1可同时检测并区分SIV、SRV、STLV的检测引物组的设计Embodiment 1 can simultaneously detect and distinguish the design of the detection primer set of SIV, SRV, STLV
分别以猴逆转录病毒(SIV)的主要核心蛋白gag基因部分序列(GenBank登录号为M74931.1)、猴逆转录病毒(SRV1,SRV2,SRV3)的p27蛋白中的部分保守基因序列(GenBank登录号分别为M11841.1、AF126467.1、M12349)、猴T淋巴细胞趋向性病毒Ⅰ型的env基因部分序列主要为靶基因,利用Primer Premier 6设计特异性的引物,分别对设计的上游引物的5’端添加Tag序列,Tag序列与引物序列之间用Spacer C18隔开,下游引物5’端添加生物素标记。最后用于PCR扩增的检测引物序列见表1。The main core protein gag gene partial sequence of simian retrovirus (SIV) (GenBank accession number is M74931.1), part of the conserved gene sequence in the p27 protein of simian retrovirus (SRV1, SRV2, SRV3) (GenBank accession number Numbers are M11841.1, AF126467.1, M12349), and the env gene partial sequence of monkey T lymphotropic virus type Ⅰ is mainly the target gene. Primer Premier 6 is used to design specific primers, and the designed upstream primers are respectively A Tag sequence was added to the 5' end, and Spacer C18 was used to separate the Tag sequence from the primer sequence, and a biotin label was added to the 5' end of the downstream primer. The sequences of the detection primers used for PCR amplification are shown in Table 1.
表1.SIV、SRV、STLV检测引物组Table 1. SIV, SRV, STLV detection primer set
实施例2可同时检测并区分SIV、SRV、STLV的方法的建立。Example 2 Establishment of a method for simultaneously detecting and distinguishing SIV, SRV, and STLV.
(1)病毒总RNA的提取:采用美基生物公司的病毒总RNA提取试剂盒分别对SIV、SRV病毒培养液中的总病毒RNA进行提取,并采用逆转录试剂盒进行逆转录成cDNA.(1) Extraction of total viral RNA: The total viral RNA in the SIV and SRV virus culture medium was extracted by using the total viral RNA extraction kit of Meiji Biotechnology Co., Ltd., and reverse-transcribed into cDNA by using the reverse transcription kit.
(2)PCR扩增反应:(2) PCR amplification reaction:
20μl反应体系含有:SIVfd 0.2μM,SIVbk 0.2μM,SRVfd0.2μM,SRVbk 0.2μM,STLV1fd 0.2μM,STLVbk0.2μM,Multiplex PCR Assay Kit中反应液10.0μl,PCR EnzymeMix 0.1μl,待检cDNA2.0μl,用DEPC水补齐到20μl;设置阳性对照和阴性对照;将配制好的PCR管混匀后离心,按如下程序进行PCR反应:94℃预变性5min;94℃变性30s,58℃退火30s,72℃延伸30s,循环33次;72℃延伸5min。The 20 μl reaction system contains: SIVfd 0.2 μM, SIVbk 0.2 μM, SRVfd 0.2 μM, SRVbk 0.2 μM, STLV1fd 0.2 μM, STLVbk 0.2 μM, multiplex PCR Assay Kit reaction solution 10.0 μl, PCR EnzymeMix 0.1 μl, cDNA to be tested 2.0 μl, Make up to 20 μl with DEPC water; set positive control and negative control; mix the prepared PCR tube and centrifuge, and perform PCR reaction according to the following procedure: 94°C pre-denaturation for 5 minutes; 94°C denaturation for 30s, 58°C for 30s, 72°C Extend at ℃ for 30s, cycle 33 times; extend at 72℃ for 5min.
(3)PCR产物与荧光编码微球杂交。(3) Hybridization of PCR products with fluorescently encoded microspheres.
A、配制荧光编码微球溶液:将包被有与设计引物的Tag序列反向互补的荧光微球(3种微球购自Luminex公司,浓度为2500个/μl,具体的SIV、SRV、STLV分别对应的荧光编码微球号为MTAG-67、MTAG-15、MTAG-56)用1.1×的Hybrdization Buffer稀释到每微升溶液中含有每种荧光编码微球50个。A. Preparation of fluorescently encoded microsphere solution: fluorescent microspheres coated with reverse complementary Tag sequences to the designed primers (three kinds of microspheres were purchased from Luminex, the concentration was 2500/μl, specific SIV, SRV, STLV Corresponding fluorescent coded microsphere numbers are MTAG-67, MTAG-15, MTAG-56) were diluted with 1.1×Hybrdization Buffer to contain 50 fluorescent coded microspheres per microliter solution.
B、配制链霉亲和素-藻红蛋白溶液:将1mg/ml的SAPE溶液用1×HybrdizationBuffer稀释到10ug/ml.B. Prepare streptavidin-phycoerythrin solution: Dilute 1mg/ml SAPE solution to 10ug/ml with 1×HybrdizationBuffer.
C、配制杂交体系:C. Prepare hybrid system:
D、杂交程序:45℃杂交35minD. Hybridization procedure: hybridization at 45°C for 35 minutes
(4)信号检测及结果判读。(4) Signal detection and result interpretation.
通过Luminex 200仪器对杂交产物进行检测及分析,读取每个样本中每种荧光微球的MFI值并统计出平均的MFI值作为判定依据。根据仪器软件设置,选取阴性对照为参考,当样本的MFI值大于1000时,可判为阳性。The hybridization products were detected and analyzed by Luminex 200 instrument, the MFI value of each fluorescent microsphere in each sample was read and the average MFI value was calculated as the basis for judgment. According to the instrument software settings, select the negative control as a reference, when the MFI value of the sample is greater than 1000, it can be judged as positive.
实施例3特异性实验Embodiment 3 specificity experiment
用实施例2的方法同时对SIV、SRV、STLV的混合cDNA模板进行检测,验证特异性。The mixed cDNA templates of SIV, SRV, and STLV were simultaneously detected by the method in Example 2 to verify the specificity.
检测结果显示:三种病毒引物彼此间没有交叉反应(见图1)。The test results showed that the three viral primers had no cross-reaction with each other (see Figure 1).
实施例4灵敏度实验Embodiment 4 Sensitivity experiment
以每个病毒的cDNA为模板,分别对应的采用SIV-F/SIV-R、SRV-F/SRV-R、STLV-F/STLV-R引物组扩增目标片段并克隆到pMD19-T载体中,构建特定质粒,然后进行10倍梯度进行稀释,用实施例2的操作方法分别对稀释后的各梯度质粒DNA进行灵敏度的检测。Using the cDNA of each virus as a template, the target fragments were respectively amplified with SIV-F/SIV-R, SRV-F/SRV-R, and STLV-F/STLV-R primer sets and cloned into the pMD19-T vector , to construct a specific plasmid, and then carry out a 10-fold gradient dilution, and use the operation method of Example 2 to detect the sensitivity of each gradient plasmid DNA after dilution.
检测结果显示:对于SIV,SIVfd/SIVbk引物组对质粒的检测灵敏度为10fg/μl;对于SRV1、SRV2、SRV3,SRVfd/SRVbk引物组对质粒的检测灵敏度分别为100fg/μl、10fg/μl、10fg/μl,对于STLV,STLVfd/STLVbk引物组对质粒的检测灵敏度为1fg/μl(见图2)。The test results showed that: for SIV, the detection sensitivity of the SIVfd/SIVbk primer set to the plasmid was 10fg/μl; for SRV1, SRV2, and SRV3, the detection sensitivity of the SRVfd/SRVbk primer set to the plasmid was 100fg/μl, 10fg/μl, and 10fg, respectively /μl, for STLV, the detection sensitivity of the STLVfd/STLVbk primer set to the plasmid is 1fg/μl (see Figure 2).
实施例5不同引物组检测效果的比较The comparison of different primer sets detection effect of embodiment 5
用实施例2的方法,采用其他的检测引物组按照实施例4的方法对各浓度的质粒进行灵敏度检测,其他检测引物组序列及检测结果如下表2和表3。Using the method of Example 2, other detection primer sets were used for sensitivity detection of plasmids of various concentrations according to the method of Example 4. The sequences and detection results of other detection primer sets are shown in Table 2 and Table 3.
表2其他检测引物组序列Table 2 Other Detection Primer Set Sequences
表3不同检测引物组的检测效果比较Table 3 Comparison of detection effects of different detection primer groups
备注:检测引物组A来自于本发明的引物组。Note: Detection primer set A is from the primer set of the present invention.
检测结果显示:本发明的检测引物组相比其他的引物组具有更高的检测灵敏度,引物彼此间干扰更小;引物组B未出现假阳性,但检测灵敏度有所下降;检测引物组C的阴性对照检测为阳性,表明检测引物组出现了干扰作用。The test result shows: the detection primer set of the present invention has higher detection sensitivity than other primer sets, and the interference between the primers is smaller; there is no false positive in primer set B, but the detection sensitivity has decreased; the detection primer set C has higher detection sensitivity. The negative control test was positive, indicating interference with the detection primer set.
本发明具有高特异性、高灵敏度、快速高效、成本低、结果准确易读等优点,适合于各级检测单位在实验动物病原检测过程中进行推广应用。The invention has the advantages of high specificity, high sensitivity, fast and high efficiency, low cost, accurate and easy-to-read results, etc., and is suitable for popularization and application in the detection process of experimental animal pathogens by detection units at all levels.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 广东省实验动物监测所<110> Guangdong Laboratory Animal Monitoring Institute
<120> 一种可同时检测并区分SIV、SRV、STLV的检测引物组及方法<120> A detection primer set and method capable of simultaneously detecting and distinguishing SIV, SRV, and STLV
<130><130>
<160> 20<160> 20
<170> PatentIn version 3.5<170> PatentIn version 3.5
<210> 1<210> 1
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 1<400> 1
acgacccggc ggaaagaaaa agt 23acgacccggc ggaaagaaaa agt 23
<210> 2<210> 2
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 2<400> 2
tgcaccagat gacgcagaca gt 22tgcaccagat gacgcagaca gt 22
<210> 3<210> 3
<211> 19<211> 19
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 3<400> 3
ayggggctac tgcyccata 19ayggggctac tgcyccata 19
<210> 4<210> 4
<211> 21<211> 21
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 4<400> 4
gccattacck gcytgttgat t 21gccattacck gcytgttgat t 21
<210> 5<210> 5
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 5<400> 5
gtgccaatca tggacctgcc 20gtgccaatca tggacctgcc 20
<210> 6<210> 6
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 6<400> 6
tcctggagcg tcgattagaa gg 22tcctggagcg tcgattagaa gg 22
<210> 7<210> 7
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 7<400> 7
atctcaatta caataacaca caaa 24atctcaatta caataacaca caaa 24
<210> 8<210> 8
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 8<400> 8
tacttcttta ctacaattta caac 24tacttcttta ctacaattta caac 24
<210> 9<210> 9
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 9<400> 9
cttaaactct acttacttct aatt 24cttaaactct acttacttct aatt 24
<210> 10<210> 10
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 10<400> 10
cgacccggcg gaaagaaaaa gt 22cgacccggcg gaaagaaaaa gt 22
<210> 11<210> 11
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 11<400> 11
tgcgccccaa atagctcagt ttt 23tgcgccccaa atagctcagt ttt 23
<210> 12<210> 12
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 12<400> 12
agctggaatg gggacaggtt cact 24agctggaatg gggacaggtt cact 24
<210> 13<210> 13
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 13<400> 13
tgcggttttc ccttctccct tct 23tgcggttttc ccttctccct tct 23
<210> 14<210> 14
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 14<400> 14
aggcagttgg ctgggttcgg tatt 24aggcagttgg ctgggttcgg tatt 24
<210> 15<210> 15
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 15<400> 15
acccagaagc taagggaacg gcat 24accccagaagc taagggaacg gcat 24
<210> 16<210> 16
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 16<400> 16
acagttctgc cacctctgca ct 22acagttctgc cacctctgca ct 22
<210> 17<210> 17
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 17<400> 17
atgcgcccca aatagctcag tttt 24atgcgcccca aatagctcag tttt 24
<210> 18<210> 18
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 18<400> 18
tggggacagg ttcactacct ggaa 24tggggacagg ttcactacct ggaa 24
<210> 19<210> 19
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 19<400> 19
agccatctcc agcccttact ggaa 24agccatctcc agcccttact ggaa 24
<210> 20<210> 20
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 20<400> 20
agaagggaga agggaaaacc gca 23agaagggaga agggaaaacc gca 23
Claims (9)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610839474 | 2016-09-21 | ||
| CN2016108394744 | 2016-09-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106636461A true CN106636461A (en) | 2017-05-10 |
| CN106636461B CN106636461B (en) | 2018-08-14 |
Family
ID=58821473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610948583.XA Active CN106636461B (en) | 2016-09-21 | 2016-10-25 | A kind of detection primer group and method that can be detected simultaneously and distinguish SIV, SRV, STLV |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106636461B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304370A (en) * | 2020-04-22 | 2020-06-19 | 广东省实验动物监测所 | A kind of rapid detection simian immunodeficiency virus SIV primer, probe and its kit and using method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1683019A (en) * | 2005-02-23 | 2005-10-19 | 中国医学科学院实验动物研究所 | A kind of method and application of constructing AIDS primate model |
| CN105624332A (en) * | 2016-02-17 | 2016-06-01 | 海南出入境检验检疫局检验检疫技术中心 | Triple real-time fluorescent quantitative PCR (polymerase chain reaction) detection method of three simian retroviruses |
-
2016
- 2016-10-25 CN CN201610948583.XA patent/CN106636461B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1683019A (en) * | 2005-02-23 | 2005-10-19 | 中国医学科学院实验动物研究所 | A kind of method and application of constructing AIDS primate model |
| CN105624332A (en) * | 2016-02-17 | 2016-06-01 | 海南出入境检验检疫局检验检疫技术中心 | Triple real-time fluorescent quantitative PCR (polymerase chain reaction) detection method of three simian retroviruses |
Non-Patent Citations (9)
| Title |
|---|
| CHARLENE S.DEZZUTTI ET AL.: ""DETECTION OF SIMIAN T-LYMPHOTROPIC VIRUS TYPE I USING THE POLYMERASE CHAIN REACTION"", 《INT.J.CANCER》 * |
| FOWLER,M.E. 等: "《动物园与野生动物医学》", 31 December 2015, 中国农业出版社 * |
| LISA JONES-ENGEL ET AL.: ""Temple Monkeys and Health Implications of Commensalism,Kathmandu, Nepal"", 《EMERGING INFECTIOUS DISEASES》 * |
| 周晓芳 等: ""Luminex系统的技术原理与应用"", 《临床检验杂志》 * |
| 孙志勇 等: ""一种快速诊断甲型H1N1流感病毒的悬浮芯片方法"", 《解放军预防医学杂志》 * |
| 孙敏 等: ""猴D型反转录病毒巢式PCR检测方法的建立"", 《中国实验动物学报》 * |
| 李兴玉: "《简明分子生物学》", 31 March 2009, 化学工业出版社 * |
| 王维鹏: "《妇幼保健临床实验诊断学》", 30 November 2013, 湖北科学技术出版社 * |
| 白春学 等: "《现代呼吸病学》", 30 November 2014, 复旦大学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111304370A (en) * | 2020-04-22 | 2020-06-19 | 广东省实验动物监测所 | A kind of rapid detection simian immunodeficiency virus SIV primer, probe and its kit and using method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106636461B (en) | 2018-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101392302B (en) | Flu/human avian influenza virus detection gene chip and production method and use | |
| CN105648115B (en) | For detecting PCR primer group, probe groups and the kit of various respiratory road pathogen | |
| CN102181532B (en) | Primer, probe and method for detecting entomophily or contact transmission pathogens by using liquid phase chip | |
| CN107475459A (en) | Differentiate the detection method of american type PRRSV classical strainses, variation strain and new virus class NADC30 strains simultaneously | |
| CN108676920A (en) | It is a kind of quickly to detect mouse norovirus primer, kit and its RT-RPA methods | |
| CN103789455B (en) | Group of real-time fluorescent QRT-PCR primers capable of detecting cattle, sheep akabane virus by one-step method, probe and usage method thereof | |
| CN107312873B (en) | A kind of multiple liquid phase genetic chip detection primer, kit and method of 5 kinds of Respiratory Tract of Mice cause of diseases of quick differentiation | |
| CN102586487B (en) | Double fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) detection kit for duck hepatitis virus I and Muscovy duck parvovirus | |
| CN104073569A (en) | Molecular marker used for diagnosing extremely severe case of hand-foot-and-mouth disease and testing method as well as kit | |
| CN113186359B (en) | Porcine Astrovirus Detection, Typing and Enrichment Multiplex PCR Rapid Diagnostic Kit | |
| CN106636461B (en) | A kind of detection primer group and method that can be detected simultaneously and distinguish SIV, SRV, STLV | |
| CN109439801A (en) | A kind of honeybee Israel acute paralysis virus real-time fluorescent RT-PCR detection reagent box and its detection method | |
| CN113215329A (en) | Primer, probe and kit for multiplex PCR detection of 7 respiratory subtype influenza viruses | |
| CN104975077B (en) | Pig source eperythrozoon fluorescent quantificationally PCR detecting kit and its application | |
| CN107937606B (en) | Reagent and method for identifying rabies virus vaccine strain and wild strain | |
| KR101236197B1 (en) | Differential detection of West nile virus and Japanese encephalitis virus | |
| CN117551812A (en) | Compositions for detecting PaBV types 2, 4 and 5 and kits and applications thereof | |
| CN104313191B (en) | Single stage method reverse transcription PCR detects and the primer of somatotype Ebola virus 5 kinds of hypotypes, probe and test kit | |
| TWI531654B (en) | Oligonucleotide probes, kit containing the same and method for pathotyping of h5 avian influenza viruses | |
| CN107988429B (en) | Reagent for detecting rabies virus and application thereof | |
| KR102276396B1 (en) | A composition and RT-qPCR based chip for detecting avian influenza viruses and method for detecting avian influenza viruses using the same | |
| CN106319091A (en) | Multiple-FIA (fluorescence immunoassay) method and kit for quickly distinguishing CDV (canine distemper virus), CPV (canine parvovirus) and RV (rabies virus) | |
| JP6853523B2 (en) | PCR using helicase | |
| CN105400908A (en) | Primer and kit for detecting channel catfish viruses through pyrosequencing technology and detecting method | |
| CN106167836B (en) | Multi-fluorescence analysis method and kit a kind of while that detect 4 plants of rat parvovirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |